Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: Tacrobell tab_Phase1_PK [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic evaluation of Tacrobell tablets (tacrolimus) sponsored by Chong Kun Dang Pharmaceutical has completed, examining immunosuppressive pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrobell

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Immunosuppressant(Organ Transplantation, RA) | Phase 1 | Status: COMPLETED